Published in Nat Biotechnol on March 02, 2014
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell (2015) 7.80
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol (2014) 5.69
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell (2014) 5.43
Lattice light-sheet microscopy: imaging molecules to embryos at high spatiotemporal resolution. Science (2014) 4.99
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol (2014) 4.41
ADVANCED IMAGING. Extended-resolution structured illumination imaging of endocytic and cytoskeletal dynamics. Science (2015) 4.12
Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature (2015) 3.77
Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell (2014) 3.76
An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol (2015) 3.74
Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature (2015) 3.64
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol (2015) 3.64
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature (2016) 3.54
Saturation editing of genomic regions by multiplex homology-directed repair. Nature (2014) 3.30
CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature (2014) 3.28
Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat Biotechnol (2014) 2.99
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol (2014) 2.75
Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs. PLoS One (2014) 2.69
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat Commun (2015) 2.56
Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell (2014) 2.55
Targeted genome editing in human repopulating haematopoietic stem cells. Nature (2014) 2.49
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature (2016) 2.15
Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol Cell (2014) 2.02
Gene expression and immunohistochemical analyses of mKast suggest its late pupal and adult-specific functions in the honeybee brain. PLoS One (2017) 1.99
Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system. Sci Rep (2014) 1.83
A mouse geneticist's practical guide to CRISPR applications. Genetics (2014) 1.81
Programmable RNA Tracking in Live Cells with CRISPR/Cas9. Cell (2016) 1.75
Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proc Natl Acad Sci U S A (2015) 1.68
Scalable and versatile genome editing using linear DNAs with microhomology to Cas9 Sites in Caenorhabditis elegans. Genetics (2014) 1.61
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Res (2014) 1.59
A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Cell (2016) 1.57
High-Throughput, High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing. Cell (2016) 1.53
CRISPR-Cas9 genome editing of a single regulatory element nearly abolishes target gene expression in mice--brief report. Arterioscler Thromb Vasc Biol (2014) 1.53
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J Clin Invest (2014) 1.45
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol (2016) 1.44
Microarray Noninvasive Neuronal Seizure Recordings from Intact Larval Zebrafish. PLoS One (2016) 1.42
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol (2015) 1.41
Genome editing technologies: defining a path to clinic. Mol Ther (2015) 1.41
A CRISPR view of development. Genes Dev (2014) 1.41
A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish. Dev Cell (2015) 1.36
Applications of CRISPR technologies in research and beyond. Nat Biotechnol (2016) 1.34
International regulatory landscape and integration of corrective genome editing into in vitro fertilization. Reprod Biol Endocrinol (2014) 1.27
Target specificity of the CRISPR-Cas9 system. Quant Biol (2014) 1.23
Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera. Nat Commun (2015) 1.22
A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res (2015) 1.20
Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation. Nat Rev Mol Cell Biol (2015) 1.20
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. Hum Gene Ther (2015) 1.18
Cas9-Guide RNA Directed Genome Editing in Soybean. Plant Physiol (2015) 1.18
Applications of CRISPR-Cas systems in neuroscience. Nat Rev Neurosci (2015) 1.18
CRISPR-Cas9-mediated single-gene and gene family disruption in Trypanosoma cruzi. MBio (2014) 1.17
Expanding the CRISPR imaging toolset with Staphylococcus aureus Cas9 for simultaneous imaging of multiple genomic loci. Nucleic Acids Res (2016) 1.14
Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression. Nucleic Acids Res (2014) 1.13
Dual sgRNA-directed gene knockout using CRISPR/Cas9 technology in Caenorhabditis elegans. Sci Rep (2014) 1.12
Advances in genome editing technology and its promising application in evolutionary and ecological studies. Gigascience (2014) 1.11
Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference. Nucleic Acids Res (2015) 1.10
CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res (2014) 1.10
A CRISPR-Cas9 System for Genetic Engineering of Filamentous Fungi. PLoS One (2015) 1.08
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes. Cell (2016) 1.08
Selective, rapid and optically switchable regulation of protein function in live mammalian cells. Nat Chem (2015) 1.08
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. Cancer Discov (2016) 1.08
Efficient generation of gene-modified pigs via injection of zygote with Cas9/sgRNA. Sci Rep (2015) 1.07
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol (2016) 1.06
Cas9 gRNA engineering for genome editing, activation and repression. Nat Methods (2015) 1.04
Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing. Hum Gene Ther (2015) 1.04
Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat Rev Genet (2016) 1.03
TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts. J Clin Invest (2015) 1.02
ChEC-seq kinetics discriminates transcription factor binding sites by DNA sequence and shape in vivo. Nat Commun (2015) 1.01
Chromatin regulation at the frontier of synthetic biology. Nat Rev Genet (2015) 1.01
A high excision potential of TALENs for integrated DNA of HIV-based lentiviral vector. PLoS One (2015) 1.01
Efficient CRISPR/Cas9 plasmids for rapid and versatile genome editing in Drosophila. G3 (Bethesda) (2014) 1.01
A proposal for validation of antibodies. Nat Methods (2016) 1.01
Single-cell epigenomics: techniques and emerging applications. Nat Rev Genet (2015) 1.00
A newly discovered Bordetella species carries a transcriptionally active CRISPR-Cas with a small Cas9 endonuclease. BMC Genomics (2015) 1.00
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice. Nat Commun (2016) 1.00
ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes. Nat Commun (2016) 0.99
Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome. Epigenetics Chromatin (2015) 0.99
The CRISPR/Cas Genome-Editing Tool: Application in Improvement of Crops. Front Plant Sci (2016) 0.99
Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity. Clin Epigenetics (2015) 0.99
Coping with drought: stress and adaptive responses in potato and perspectives for improvement. Front Plant Sci (2015) 0.98
Optical Control of CRISPR/Cas9 Gene Editing. J Am Chem Soc (2015) 0.98
Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis. Hum Mol Genet (2015) 0.98
Generation of gene-modified goats targeting MSTN and FGF5 via zygote injection of CRISPR/Cas9 system. Sci Rep (2015) 0.98
CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs. Sci Rep (2015) 0.98
Stimuli-responsive nanomaterials for biomedical applications. J Am Chem Soc (2015) 0.97
Developments in the tools and methodologies of synthetic biology. Front Bioeng Biotechnol (2014) 0.97
Stem cell-based therapies for cancer treatment: separating hope from hype. Nat Rev Cancer (2014) 0.96
Comparison of Cas9 activators in multiple species. Nat Methods (2016) 0.96
Resources for the design of CRISPR gene editing experiments. Genome Biol (2015) 0.95
An enhanced gene targeting toolkit for Drosophila: Golic+. Genetics (2015) 0.95
A versatile two-step CRISPR- and RMCE-based strategy for efficient genome engineering in Drosophila. G3 (Bethesda) (2014) 0.95
CRISPR/Cas9-mediated endogenous protein tagging for RESOLFT super-resolution microscopy of living human cells. Sci Rep (2015) 0.94
CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases. Mol Neurodegener (2015) 0.94
Determining the specificities of TALENs, Cas9, and other genome-editing enzymes. Methods Enzymol (2014) 0.93
New cell sources for T cell engineering and adoptive immunotherapy. Cell Stem Cell (2015) 0.93
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter. Oncotarget (2016) 0.93
A chemical-genetic interaction map of small molecules using high-throughput imaging in cancer cells. Mol Syst Biol (2015) 0.93
A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges. Chromosome Res (2015) 0.92
Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators. Genome Res (2015) 0.92
A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing. BMC Genomics (2014) 0.92
Analyzing CRISPR genome-editing experiments with CRISPResso. Nat Biotechnol (2016) 0.92
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
A TALE nuclease architecture for efficient genome editing. Nat Biotechnol (2010) 26.47
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00
Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol (2013) 21.32
A simple cipher governs DNA recognition by TAL effectors. Science (2009) 19.99
DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol (2013) 19.99
Genome editing with engineered zinc finger nucleases. Nat Rev Genet (2010) 18.88
CRISPR/Cas, the immune system of bacteria and archaea. Science (2010) 18.72
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature (2011) 17.38
RNA-guided genetic silencing systems in bacteria and archaea. Nature (2012) 17.12
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A (2012) 16.48
Genome engineering using the CRISPR-Cas9 system. Nat Protoc (2013) 15.98
RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol (2013) 15.51
RNA-programmed genome editing in human cells. Elife (2013) 14.82
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 14.28
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell (2013) 13.43
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell (2013) 13.37
FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol (2012) 12.97
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol (2011) 12.86
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (2013) 12.36
A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput Biol (2005) 11.82
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol (2013) 11.35
Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell (2008) 11.24
Genetic screens in human cells using the CRISPR-Cas9 system. Science (2013) 10.75
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res (2011) 10.43
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55
Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nat Methods (2010) 8.86
Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics (2013) 8.56
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol (2013) 8.40
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res (2013) 7.77
Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol (2010) 7.70
Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res (2013) 7.41
TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol (2012) 7.01
Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc Natl Acad Sci U S A (2011) 6.89
Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res (2013) 6.89
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol (2014) 6.85
DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct (2000) 6.61
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res (2013) 6.19
Optical control of mammalian endogenous transcription and epigenetic states. Nature (2013) 6.09
Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods (2013) 5.93
Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell (2013) 5.40
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol (2013) 4.72
Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep (2013) 4.72
CRISPR RNA-guided activation of endogenous human genes. Nat Methods (2013) 4.69
Genome engineering with zinc-finger nucleases. Genetics (2011) 4.66
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods (2013) 4.61
Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol (2013) 4.58
RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci U S A (2011) 4.58
Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc Natl Acad Sci U S A (2013) 4.57
Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol (2013) 4.19
Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly. Nat Protoc (2006) 4.16
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res (2013) 4.11
Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell (2013) 4.05
Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat Biotechnol (2013) 3.84
Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol (2013) 3.82
Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol (2013) 3.65
Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci U S A (2013) 3.53
Design, construction and in vitro testing of zinc finger nucleases. Nat Protoc (2006) 3.51
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res (2013) 3.51
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods (2013) 3.26
Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 3.20
Precision genome engineering with programmable DNA-nicking enzymes. Genome Res (2012) 3.05
Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis, tobacco, sorghum and rice. Nucleic Acids Res (2013) 2.99
Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods (2013) 2.89
Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol (2013) 2.89
Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics (2013) 2.87
Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS One (2013) 2.74
Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res (2013) 2.73
Preassembled zinc-finger arrays for rapid construction of ZFNs. Nat Methods (2011) 2.54
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep (2013) 2.48
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol (2013) 2.44
Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics (2013) 2.44
A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Res (2006) 2.38
Single-strand interruptions in replicating chromosomes cause double-strand breaks. Proc Natl Acad Sci U S A (2001) 2.31
Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res (2012) 2.26
RNA-guided genome editing in plants using a CRISPR-Cas system. Mol Plant (2013) 2.25
Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions. Genetics (2013) 2.22
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res (2012) 2.14
Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods (2012) 2.07
Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme. Genome Res (2012) 2.02
Transgene-free genome editing in Caenorhabditis elegans using CRISPR-Cas. Genetics (2013) 1.95
Modular system for the construction of zinc-finger libraries and proteins. Nat Protoc (2010) 1.87
Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis. Genesis (2013) 1.84
An optimized two-finger archive for ZFN-mediated gene targeting. Nat Methods (2012) 1.84
Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information. Virology (2012) 1.80
CRISPR/Cas9-targeted mutagenesis in Caenorhabditis elegans. Genetics (2013) 1.79
Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Curr Gene Ther (2011) 1.76
Heritable custom genomic modifications in Caenorhabditis elegans via a CRISPR-Cas9 system. Genetics (2013) 1.72
Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans. Genetics (2013) 1.69
RNA-guided genome editing for target gene mutations in wheat. G3 (Bethesda) (2013) 1.64
The CRISPR/Cas system mediates efficient genome engineering in Bombyx mori. Cell Res (2013) 1.52
Double-strand breaks arising by replication through a nick are repaired by cohesin-dependent sister-chromatid exchange. EMBO Rep (2006) 1.51
Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. J Mol Cell Biol (2014) 1.41